CGON - Company ID 0001991792
The table below shows CG Oncology, Inc.'s balance sheet line items across its last 2 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 |
|---|---|---|
| Cash & equivalents | $32.49M | $257.07M |
| Short-term investments | $709.66M | $484.93M |
| Receivables | - | - |
| Inventory | $1.56M | - |
| Total current assets | $759.48M | $754.21M |
| Property, plant & equipment | $15.60M | $272.00K |
| Goodwill | $10.30M | - |
| Total assets | $791.59M | $754.80M |
| Accounts payable | $5.71M | $6.52M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current liabilities |
| $30.84M |
| $21.37M |
| Long-term debt | $3.00M | - |
| Total liabilities | $38.99M | $21.42M |
| Retained earnings | -$378.98M | -$217.98M |
| Total equity | $752.60M | $733.38M |